Sitagliptin: all 313 studies that test it
Page 3 of 4. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.
- Oral Hypoglycemic Therapy for Monogenic Variant Carriers of the Joslin Medalist StudyCompletedNCT04409795Phase 2/3
- The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic PatientsStatus unknownNCT04365517Phase 3
- Effects of Sitagliptin in Individuals With Genetically Decreased DPP4Active, not recruitingNCT04323189Phase 4
- Effects of SGLT2i on the Cognitive Function in T2DM Patient (ESCDP)CompletedNCT04304261Phase 3
- Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic AgentsStatus unknownNCT04287387Phase 4
- Comparing the Effect of Sitagliptin/Metformin and Metformin in PCOS PatientsStatus unknownNCT04268563Phase 1/2
- Involvement of Dipeptidyl Peptidase-4 and Sodium-glucose Co-transporter-2 in Extrapancreatic Glucagon SecretionCompletedNCT04061473Not applicable
- Effect of Neprilysin on Glucagon-Like Peptide-1 in Patients With Type 2 DiabetesCompletedNCT03893526Phase 4
- Drug Interaction Study Between Dorzagliatin and SitagliptinCompletedNCT03790839Phase 1
- The Effects of Neprilysin on Glucagon-like Peptide-1CompletedNCT03717688Phase 4
- Glucagon-like Peptide-1 Levels, Insulin Resistance and Insulin Sensitivity Index in Type 2 Diabetes MellitusCompletedNCT03659461Not applicable
- Effects of a Dipeptidyl Peptidase-4 Inhibitor Sitagliptininsulin on the Progression of Coronary Atherosclerosis in Patients With Type 2 DiabetesStatus unknownNCT03602638Phase 4
- Sitagliptin vs. Pioglitazone as add-on Treatments in Patients With Type 2 Diabetes Uncontrolled on the Full-dose Metformin Plus SulfonylureaCompletedNCT03125694Phase 3
- Sitagliptin Improved Beta Cell Function and Prevented a Conversion Rate to Impaired Glucose Tolerance and Type 2 Diabetes in Metformin Intolerant Obese Women With Polycystic Ovary SyndromeCompletedNCT03122041Phase 4
- Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight LossCompletedNCT02941445Phase 4
- Evaluation of the Effect of Sitagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 DiabetesStatus unknownNCT02900417Not applicable
- HbA1c Variability in Type II DiabetesActive, not recruitingNCT02879409Not applicable
- CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1)CompletedNCT02827890Phase 1
- The Effect of DPP4 Inhibitor on Vasclular HealingStatus unknownNCT02802644Phase 4
- Feed-Back Suppression of Meal-Induced Glucagon-like Peptide 1 (GLP-1) SecretionCompletedNCT02749032Phase 1
- Drug Transporter Interaction Study PHENTRA_2015_KPUKCompletedNCT02743260Phase 4
- Accelerated Wound Healing in Diabetic Ulcers by SitagliptinWithdrawnNCT02675335Phase 3
- Effect of Sitagliptin on Progression of Coronary Intermediate LesionCompletedNCT02655757Phase 4
- TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes.CompletedNCT02653209Phase 4
- A Pilot Study to Evaluate the Safety of a 3 Weeks Sitagliptin Treatment in HCC Patients Undergoing Liver ResectionCompletedNCT02650427Phase 1
- Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2DCompletedNCT02607410Phase 4
- Sitagliptin Effects on Arterial Vasculature and Inflammation in ObesityCompletedNCT02576288Phase 2
- Treatment of Hypoglycemia Following Gastric Bypass SurgeryCompletedNCT02527993Phase 4
- Effects of DPP-4 Inhibition on Calcium and Bone Metabolism in Type 2 Diabetes MellitusWithdrawnNCT02444364Early Phase 1
- Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DMStatus unknownNCT02443922Not applicable
- Sitagliptin and Endothelial DysfunctionStatus unknownNCT02406950Phase 3
- Study on Exploring the Effect of DPP-4 Inhibitors on β-cell Function by Using the Two-step Hyperglycemic ClampStatus unknownNCT02386943Phase 4
- Dipeptidyl Peptidase-4 Inhibition and Narrow-band Ultraviolet-B Light in Psoriasis (DINUP)CompletedNCT02347501Phase 2
- Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination TherapyCompletedNCT02338921Phase 4
- Influence of Gut Hormones on Food Intake After Roux-en-Y Gastric Bypass SurgeryCompletedNCT02336659Not applicable
- Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes TrialCompletedNCT02330406Phase 4
- Effects of Sitaglpitin on Endothelial Function During the OGTT in T2DMStatus unknownNCT02301806Phase 4
- Sitagliptin and Brown Adipose TissueCompletedNCT02294084Phase 4
- Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRIWithdrawnNCT02263677Phase 4
- Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical UnitWithdrawnNCT02250794Phase 4
- Correlation Between Plasma- and Endothelial DPP-4 ActivityCompletedNCT02192853Phase 4
- Bioavailability of BI 10773 and Sitagliptin in Healthy Male VolunteersCompletedNCT02172196Phase 1
- DPP-4 Inhibition, Incretins and Islet FunctionCompletedNCT02089438Phase 4
- A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance TestCompletedNCT01936025Phase 2
- Effect of the DPP-4 Inhibitor Sitagliptin on Islet Function After Mixed Meal in Patients With Type 2 DiabetesCompletedNCT01901861Not applicable
- Triple Therapy in Type 2 Diabetic PatientsStatus unknownNCT01895569Phase 4
- Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)CompletedNCT01890629Phase 4
- Sitagliptin Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery DiseaseCompletedNCT01863147Phase 4
- MASTERMIND - Understanding Individual Variation in Treatment Response in Type 2 DiabetesCompletedNCT01847144Phase 4
- SAFEGUARD: Pleiotropic Effects of Incretin Based TherapiesCompletedNCT01744236Phase 4
- Sitagliptin in Type I Diabetic PatientsWithdrawnNCT01741103Not applicable
- Treatment of Dysglycemia Using Sitagliptin in Adolescents With Cystic FibrosisCompletedNCT01721382Phase 1
- A Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 DiabetesCompletedNCT01718093Phase 4
- ß-Cell Function and Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients With Moderate HyperglycemiaStatus unknownNCT01717911Phase 4
- Efficacy and Safety Comparative Study of Sitagliptin,Vildagliptin and SaxagliptinStatus unknownNCT01703637Not applicable
- Study of Comparing the Different Effect of DPP-4 Inhibitors and Sulfonylurea by Using "Biphase-Hyperglycemic Clamp"Status unknownNCT01660386Phase 4
- Treatment With Sitagliptin in Non-obese Japanese Patients With Type 2 Diabetes MellitusStatus unknownNCT01642108Not applicable
- Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 DiabetesCompletedNCT01624116Not applicable
- Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763CompletedNCT01619332Phase 1/2
- A Pilot Study Evaluating Safety of Sitagliptin Combined With Peg-IFN Alfa-2a + Ribavirin in Chronic Hepatitis C PatientsTerminatedNCT01567540Phase 1
- MK-0431/ONO-5435 Phase III Clinical Trial-Rapid-acting Insulin Secretagogue Add-on Study in Patients With Type 2 DiabetesCompletedNCT01517321Phase 3
- A Study to Evaluate the Pharmacodynamic Effects of Single-Dose Co-Administration of LX4211 With Januvia® in Type 2 DiabeticsCompletedNCT01441232Phase 1
- Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and SitagliptinCompletedNCT01422590Phase 1
- Efficacy and Safety of TAK-875 in Combination With Sitagliptin in Participants With Type 2 Diabetes MellitusCompletedNCT01414920Phase 2
- Effects of Sitagliptin on Type 2 Diabetes Mellitus Patients on Treatment With Metformin and InsulinCompletedNCT01341717Phase 4
- Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver DiseasesStatus unknownNCT01337440Phase 4
- Metformin and Sitagliptin in Women With Previous Gestational DiabetesCompletedNCT01336322Phase 2
- Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 DiabetesTerminatedNCT01260246Not applicable
- Sitagliptin in Cystic Fibrosis-Related DiabetesTerminatedNCT01257464Phase 2
- Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes MellitusCompletedNCT01235819Phase 4
- Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes (LADA)CompletedNCT01159847Phase 1/2
- Treatment of Latent Autoimmune Diabetes of the AdultCompletedNCT01140438Not applicable
- A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Sitagliptin When Given Together to Healthy SubjectsCompletedNCT01104532Phase 1
- Sitagliptin Versus Insulin Dose Increase in Type 2 Diabetes on Insulin TreatmentCompletedNCT01100125Phase 4
- Vascular Effects of Sitagliptin in Diabetes MellitusStatus unknownNCT01096277Phase 4
- Investigate the Effect of AZD1656 on the Pharmacokinetics of Sitagliptin in Patients With Type 2 Diabetes MellitusCompletedNCT01095991Phase 1
- Role of Interleukin-6 in ExerciseCompletedNCT01073826Not applicable
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses of JNJ-38431055, Sitagliptin, and Co-administration of JNJ-38431055 and SitagliptinCompletedNCT01054118Phase 1
- Sitagliptin in Prevention of Type 2 Diabetes MellitusWithdrawnNCT01038648Phase 3
- Assessing Glucose Effects of Sitagliptin (Januvia) in Adult Patients With Type 1 DiabetesCompletedNCT00978796Phase 4
- A Study of the Effects of Sitagliptin (MK0431) and Metformin on Incretin Hormone Concentrations (0431-050)(COMPLETED)CompletedNCT00975052Phase 1
- Predictive Parameters for Efficacy of Sitagliptin and Metformin CombinationCompletedNCT00969566Phase 4
- Effect of Sitagliptin on Endothelial Progenitor CellsCompletedNCT00968006Phase 4
- Effect of Sitagliptin in Impaired Glucose ToleranceStatus unknownNCT00961363Phase 2
- Clinical Trial to Investigate the Pharmacokinetics/Pharmacodynamics of SitagliptinCompletedNCT00960453Phase 1
- Effect of Sitagliptin on Postprandial Lipoprotein MetabolismTerminatedNCT00939939Phase 4
- MK-0431/ONO-5435 Phase III Clinical Trial - Insulin Add-on Study for Patients With Type 2 Diabetes MellitusCompletedNCT00854035Phase 3
- Effect of Sitagliptin on Graft Function Following Islet TransplantationTerminatedNCT00853944Phase 3
- Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to DysinsulinismCompletedNCT00847080Phase 4
- Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy SubjectsCompletedNCT00842556Phase 1
- Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy IndividualsCompletedNCT00813228Phase 1
- Sitagliptin Versus Sulphonylurea in Type 2 Diabetes During RamadanTerminatedNCT00766441Phase 4
- How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin.CompletedNCT00747383Not applicable
- Sitagliptin in Renal Transplant RecipientsCompletedNCT00740363Phase 4
- Bone Turnover in Type 2 Diabetes PatientsStatus unknownNCT00732121Phase 4
- Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism in Males With the Metabolic SyndromeCompletedNCT00721552Not applicable
- Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative StressStatus unknownNCT00699322Phase 4
- The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and InflammationStatus unknownNCT00696982Not applicable
- A Study of MK0431 in Patients WIth Hepatic Insufficiency (0431-017)(COMPLETED)CompletedNCT00696826Phase 1
- Quantification of the Dipeptidyl Peptidase (DPP)-4 Inhibition-mediated Enhancement of the Activity of the Entero-insular AxisCompletedNCT00683735Phase 2/3